UPDATE: Optimer's antibiotic received FDA approval on Fri. What a ride since then!!!

Finally, Optimer Pharma's (OPTR) antibiotic drug candidate, fidaxomicin, was approved by the US drug regulator.  Because of the unique timing of the announcement, being very late on a Friday just before the Memorial Day long weekend, a 'strange' trading pattern had immediately followed the drug approval.